Blog Archives

An annual Sjogren’s treatment update for 2020

2020 has been a long year for everyone, and Sjogren’s patients aren’t excluded. I’ve encountered some technical difficulties with this site which delayed this post, but I believe the significant issues have been fixed. The most unfortunate news is that

Posted in Clinical Trials, Treatment Tagged with: ,

Bad news for Rituxan fans

I try to keep my research-oriented posts focussed on positive news, but occasionally some bad news pops up that needs to be shared. Rituxan (generic Rituximab) is a biologic monoclonal antibody used to treat rheumatoid arthritis and various cancers. As a

Posted in Clinical Trials, Research, Treatment Tagged with:

Hope for 2016 – 5 upcoming treatments for Sjogren’s Syndrome

Happy new year everyone! Holiday and new years celebrations tend to evoke a lot of memories for me, particularly of healthier times before SS symptoms. In an effort to focus on the positive, I decided to look over promising treatment

Posted in Clinical Trials, Research, Treatment Tagged with: , ,

Two more Sjogren’s Syndrome drugs enter clinical trials

After some new biologics entered clinical trials at the beginning of the year, things have been quiet on the clinical testing front. That has just changed, as two new investigative drugs have entered the market: UCB5857 and LY3090106. LY3090106 first appeared in a phase 1 clinical

Posted in Clinical Trials, Treatment Tagged with:

Another biologic enters phase 2 testing for SS

The clinical trial is not yet open for recruitment, and it isn’t clear from the posting where recruitment will occur. The new biologic is identified as AMG 557/MEDI5872 and produced by Amgen and AstraZeneca. The drug already completed a Phase 1 trial for

Posted in Clinical Trials, Research, Treatment Tagged with:

Two new clinical trials for Sjogren’s drugs from Novartis

Novartis, a Swiss pharmaceutical company, has opened clinical trials for CFZ533, a new biologic drug for the treatment of Sjogren’s Syndrome and Rheumatoid Arthritis. The trial is currently open in the UK, though many other sites will eventually be available,

Posted in Clinical Trials, Research, Treatment Tagged with:
WordPress Appliance - Powered by TurnKey Linux